Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Gate2brain SLStartup |
Active Organization- |
Inactive Organization Gate2brain SLStartup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ewing Sarcoma | Preclinical | ES | Gate2brain SLStartup | 25 Mar 2021 |